Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy

Area of Science:

• Oncology
• Nanotechnology
• Materials Science

Background:

• Cancer remains a leading cause of global mortality, with current treatments like chemotherapy and radiotherapy exhibiting limited efficacy and significant side effects.
• The development of novel therapeutic strategies is crucial to overcome the limitations of existing cancer treatments.
• Nanotechnology offers advanced solutions for clinical treatment, particularly in developing targeted drug delivery systems.

Purpose of the Study:

• To review the application of polymer nanoparticles in cancer therapy.
• To highlight the role of polymer nanoparticles in drug delivery, gene therapy, and early diagnostics.
• To discuss the potential of polymer nanoparticles to improve tumor selectivity and reduce treatment toxicity.

Main Methods:

• Review of scientific literature on polymer nanoparticles in cancer research.
• Analysis of polymer nanoparticles as nano-drug delivery systems (NDDSs).
• Examination of polymer nanoparticles for applications in drug delivery, gene therapy, and diagnostics.

Main Results:

• Polymer nanoparticles are effective carriers for tumor-specific drug delivery, enabling slow release of anticancer agents.
• These nanoparticles enhance biocompatibility and reduce the toxicity associated with conventional cancer therapies.
• Polymer nanoparticles show promise in non-invasive drug delivery, gene therapy, and early cancer diagnostics.

Conclusions:

• Polymer nanoparticles represent a significant advancement in non-invasive cancer treatment strategies.
• Their application in drug delivery, gene therapy, and diagnostics holds great potential for improving patient outcomes.
• Further research into polymer nanoparticles can lead to more effective and less toxic cancer therapies.